Latest Sarissa Capital Management LP Stock Portfolio
Sarissa Capital Management LP Performance:
2024 Q3: -5.79%YTD: -22.61%2023: 3.51%
Performance for 2024 Q3 is -5.79%, and YTD is -22.61%, and 2023 is 3.51%.
About Sarissa Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Sarissa Capital Management LP reported an equity portfolio of $402.3 Millions as of 30 Sep, 2024.
The top stock holdings of Sarissa Capital Management LP are INVA, IRWD, GILD. The fund has invested 34.9% of it's portfolio in INNOVIVA INC and 16.8% of portfolio in IRONWOOD PHARMACEUTICALS INC.
The fund managers got completely rid off BIOCRYST PHARMACEUTICALS INC (BCRX) stocks. They significantly reduced their stock positions in BIOGEN INC (BIIB) and GILEAD SCIENCES INC (GILD). Sarissa Capital Management LP opened new stock positions in LANTHEUS HLDGS INC (LNTH).
The top stock holdings of Sarissa Capital Management LP are INVA, IRWD, GILD. The fund has invested 34.9% of it's portfolio in INNOVIVA INC and 16.8% of portfolio in IRONWOOD PHARMACEUTICALS INC.
The fund managers got completely rid off BIOCRYST PHARMACEUTICALS INC (BCRX) stocks. They significantly reduced their stock positions in BIOGEN INC (BIIB) and GILEAD SCIENCES INC (GILD). Sarissa Capital Management LP opened new stock positions in LANTHEUS HLDGS INC (LNTH).
Sarissa Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Sarissa Capital Management LP made a return of -5.79% in the last quarter. In trailing 12 months, it's portfolio return was -13.63%.
New Buys
| Ticker | $ Bought |
|---|---|
| lantheus hldgs inc | 2,853,500 |
New stocks bought by Sarissa Capital Management LP
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| biogen inc | -95.81 |
| gilead sciences inc | -30.81 |
Sarissa Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biocryst pharmaceuticals inc | -6,761,960 |
Sarissa Capital Management LP got rid off the above stocks
Sector Distribution
Sarissa Capital Management LP has about 100% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
Sarissa Capital Management LP has about 29% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 51.7 |
| LARGE-CAP | 29 |
| MID-CAP | 15.3 |
| MICRO-CAP | 4.1 |
Stocks belong to which Index?
About 84.3% of the stocks held by Sarissa Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 67.1 |
| S&P 500 | 17.2 |
| Others | 15.7 |
Sarissa Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Sarissa Capital Management LP
Sarissa Capital Management LP has 10 stocks in it's portfolio. IRWD proved to be the most loss making stock for the portfolio. INVA was the most profitable stock for Sarissa Capital Management LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMRN | amarin corp plc | 3.87 | 24,850,600 | 15,578,900 | unchanged | 0.00 | ||
| BCRX | biocryst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BIIB | biogen inc | 1.30 | 26,950 | 5,223,990 | reduced | -95.81 | ||
| CYTK | cytokinetics inc | 14.57 | 1,110,000 | 58,608,000 | unchanged | 0.00 | ||
| GILD | gilead sciences inc | 15.91 | 763,333 | 63,997,800 | reduced | -30.81 | ||
| INVA | innoviva inc | 34.93 | 7,277,000 | 140,519,000 | unchanged | 0.00 | ||
| IRWD | ironwood pharmaceuticals inc | 16.78 | 16,390,000 | 67,526,800 | unchanged | 0.00 | ||
| LNTH | lantheus hldgs inc | 0.71 | 26,000 | 2,853,500 | new | |||
| NBIX | neurocrine biosciences inc | 11.76 | 410,483 | 47,295,900 | unchanged | 0.00 | ||
| RGLS | regulus therapeutics inc | 0.07 | 185,183 | 290,737 | unchanged | 0.00 | ||
| VOR | vor biopharma inc | 0.11 | 618,000 | 432,600 | unchanged | 0.00 | ||